Concepedia

Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration

Dženita Smailhodzic, Philipp S. Muether, John Chen, Angela Kwestro, Alice Yang Zhang, Amer Omar, Johannes P. H. van de Ven, Jan E.E. Keunen, Bernd Kirchhof, Carel B. Hoyng,

Ophthalmology · 2012 · 110 citations · 31 references

Open access

Concepts

MedicineGeneticsOphthalmologyMedical GeneticsOcular GeneticsPharmacogeneticsAge-related Macular DegenerationAge-related Visual ImpairmentMacular DegenerationMacular DiseaseMacular DisordersAdvanced Age-related Macular DegenerationAge-related Macular Degeneration ProgressionCumulative Treatment Effect EstimationDisease-specific Risk AllelesHla Risk AllelesLate Age-related Macular DegenerationMultiple Alleles

References

31

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

Medicine, Ophthalmology, Surgery +12

Complement Factor H Polymorphism in Age-Related Macular Degeneration

Robert J. Klein, Caroline J. Zeiss, Emily Y. Chew et al. · Science · 2005 · 4.5K citations

Medicine, Immunology, Ophthalmology +14

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss

Archives of Ophthalmology · 2001 · 3.3K citations · Full text

Medicine, Nutrition, Ophthalmology +17

Prevalence of Age-Related Macular Degeneration in the United States

Archives of Ophthalmology · 2004 · 2.7K citations · Full text

Medicine, Ophthalmology, Population Health Sciences +15

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine · 2011 · 2.6K citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12